Teresa Lozano Selected Research

Teresa Lozano Research Topics

Disease

33	Neoplasms (Cancer) 01/2023 - 11/2010
5	Hemorrhage 01/2020 - 10/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2017
4	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 09/2017
4	Acute Coronary Syndrome 01/2020 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 08/2007
2	Melanoma (Melanoma, Malignant) 01/2023 - 04/2021
2	Multiple Myeloma 01/2023 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2019 - 08/2012
2	Inflammation (Inflammations) 01/2018 - 04/2012
1	Atrial Fibrillation 09/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023
1	Bites and Stings (Sting) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Myocardial Infarction 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Starvation 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Cardiotoxicity 09/2019
1	Anemia 01/2019
1	Lymphoma (Lymphomas) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Leukemia 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Bronchiolitis Obliterans Syndrome 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Heart Failure 07/2008

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2012
6	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
6	AntigensIBA 01/2022 - 04/2012
5	Peptides (Polypeptides)IBA 02/2021 - 10/2015
4	VaccinesIBA 01/2020 - 08/2012
4	omega-Chloroacetophenone (Mace)IBA 01/2020 - 10/2017
4	LigandsIBA 01/2020 - 08/2012
4	AntibodiesIBA 01/2018 - 01/2017
3	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2020
3	TicagrelorIBA 01/2020 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2022
2	Fibronectins (Fibronectin)IBA 01/2022 - 08/2012
2	poly ICLCIBA 01/2020 - 07/2019
2	Poly I-CIBA 01/2020 - 08/2012
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2017
2	Clopidogrel (Plavix)FDA Link 01/2020 - 01/2018
2	Prasugrel Hydrochloride FDA Link 01/2020 - 01/2018
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2019 - 01/2018
2	EpitopesIBA 09/2017 - 11/2010
1	Single-Domain AntibodiesIBA 01/2023
1	Toll-Like Receptor AgonistsIBA 01/2023
1	Interleukin-12 (IL 12)IBA 09/2022
1	LuciferasesIBA 09/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Essential Amino AcidsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	ParaffinIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021
1	bis(3',5')-cyclic diguanylic acidIBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	CytokinesIBA 10/2019
1	Therapeutic UsesIBA 07/2019
1	Toll-Like Receptor 4IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Chloride-Bicarbonate AntiportersIBA 01/2018
1	carvoneIBA 01/2018
1	Combined VaccinesIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Blocking AntibodiesIBA 01/2018
1	Nucleosomes (Nucleosome)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Cancer VaccinesIBA 06/2016
1	OligonucleotidesIBA 06/2016
1	Sorafenib (BAY 43-9006)FDA Link 10/2015
1	Phosphotransferases (Kinase)IBA 09/2015
1	src-Family KinasesIBA 09/2015
1	Protein Kinases (Protein Kinase)IBA 09/2015
1	LipidsIBA 08/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2012
1	AnaphylatoxinsIBA 04/2012
1	Recombinant ProteinsIBA 04/2012
1	Viral VaccinesIBA 04/2012
1	pro-brain natriuretic peptide (1-76)IBA 07/2008
1	Natriuretic PeptidesIBA 07/2008

Therapy/Procedure

22	Therapeutics 09/2023 - 01/2017
8	Immunotherapy 01/2023 - 06/2016
1	Ablation Techniques 01/2021
1	Intravenous Injections 08/2012